Broncolin, S.A. de C.V.

Warning LetterOpen

MexicoFEI 3009331372Issued Dec 21, 2020

View FDA's record for FEI 3009331372

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3009331372.

Violations0

Issue DateDec 21, 2020

Product TypeDrugs

StatusOpen

Letter Details

Firm: Broncolin, S.A. de C.V.
Location: Mexico
FEI Number: 3009331372
Country: Mexico
Issue Date: December 21, 2020
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Based on limited metadata, the FDA issued a warning letter to Broncolin, S.A. de C.V., a drug manufacturer, on December 21, 2020. While the specific violations are not detailed in the available metadata, the warning letter indicates regulatory concerns with the company's drug products or manufacturing practices. The action falls under FDA's drug product oversight authority, though the specific issuing office and detailed violation count are not provided in this summary record.

Broncolin, S.A. de C.V. FDA Warning Letter, December 21, 2020